Effects of different classes of drugs on the passive cutaneous anaphylaxis.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D006168:Guinea Pigs; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D051379:Mice; D010323:Passive Cutaneous Anaphylaxis; D010653:Phenylbutazone / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology*; D011346:Prochlorperazine / Q000494:pharmacology; D011395:Promazine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D012980:Sodium Salicylate / Q000494:pharmacology; D013974:Thyroxine / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D011113:Polymyxins; D012110:Reserpine; D007490:Iproniazid; D010653:Phenylbutazone; D011395:Promazine; D013974:Thyroxine; D002746:Chlorpromazine; D012980:Sodium Salicylate; D011346:Prochlorperazine